EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Can-Fite Biopharma Ltd (CANF) had EBIT Margin of -1206.23% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.67M |
|
$-7.88M |
|
-- |
|
$0.67M |
|
$8.80M |
|
$-8.13M |
|
$0.25M |
|
$-7.88M |
|
$-7.88M |
|
$-7.88M |
|
$-7.88M |
|
$-7.88M |
|
$-7.88M |
|
$-8.13M |
|
$-8.12M |
|
7.25M |
|
7.25M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$8.98M |
|
$0.03M |
|
$0.14M |
|
$9.12M |
|
$2.05M |
|
-- |
|
$1.63M |
|
$3.68M |
|
$5.44M |
|
$5.44M |
|
$5.44M |
|
9.94M |
|
| Cash Flow Statement Financials | |
$-7.64M |
|
$1.50M |
|
$6.71M |
|
$4.28M |
|
$4.83M |
|
$0.55M |
|
$0.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1206.23% |
|
|
EBIT Margin |
-1206.23% |
-1205.19% |
|
-1169.14% |
|
-1169.14% |
|
$-7.64M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-144.96% |
|
-144.96% |
|
-86.40% |
|
-144.96% |
|
$0.55 |
|
$-1.05 |
|
$-1.05 |
|